24th January 2021
The Fourth session of COVIPOCUS2021 was held on 23rd January 2021 from 6:30PM- 9:30PM (India Time). Delegates from all over the world participated in the conference. The meeting was also attended by 10 international leaders.
Dr. Christopher Fung from Michigan University Emergency Medicine Residency Program
Dr. Fung discussed about the various expanded uses of POCUS and current literature and recommendation for its use with patients with COVID19.
Prof. Prabath Nanayakkara from Netherlands and The Founder Member of The World Academic Council of Emergency Medicine.
Prof. Prabath discussed about creating the infrastructure for Randomized Control Trials in POCUS.
Special Session of Phase Zero Trials Team
A special presentation was done by Mr. Kevin Lee from Phase Zero Trials where we discussed about Image Driven RCT in POCUS and how latest technologies could bank and analyze the volumes of data being gathered from across the world.
Open House Discussion:
A Very vibrant discussion was held on various factors related to variability, bias and anthropology when collecting POCUS data across the world.
Dr. Vali (Tanzania) Dr. Fung (USA), Dr. Prabath (Netherlands) led the discussions.
Countries such as Turkey, Japan, France, South America, Spain and a few others have medical education in national languages. It was reemphasized to share knowledge on POCUS from these Nations.
Medical Students and Licensed Medical Doctors need different research educational training standards and that would work to decrease interpersonal variability in data collection.
Special Remarks were delivered by Dr. Patanjali Dev Nayyar from WHO SEARO on important aspects of strategies related to growing the use of POCUS in Medicine and health facilities across India.
Featured Research Presentation:
UTILITY OF LUS SCORING SYSTEM DURING COVID-19 PANDEMIC
Presented By Dr. Sanjan. A Assistant Professor of Emergency Medicine, Kasturba Medical College, Manipal, India
The COVID-19 pandemic, has affected healthcare systems around the globe, especially in triaging and prioritizing patients for testing and isolation, especially when dealing with atypical presentations. Computed tomography (CT) scan of the chest is the imaging modality of choice. Interstitial involvement was the main finding. Lung ultrasound (LUS) is an alternative to chest CT that had gained popularity in the triage, diagnosis, and follow up and even to prognosticate the COVID patient. Recent studies had shown the utility of LUS in the diagnosis of COVID-19 that showed various findings ranging from A lines to consolidation depending on the severity of the infection. In addition to this LUS scoring system has gained popularity with score ranging from 0 to 36. Studies have shown LUS could be used for strategizing the management plan of the patients, could diagnose early VAP. Increase in LUS score had a relation with severity of ARDS or worsening respiratory failure, whereas decrease in LUS had been used to wean the patient from ventilator.